Overview
Molecule is the infrastructure layer of decentralized science, providing the IP-NFT framework that underpins most biotech DAOs. The platform lets research communities fund biomedical research and trade the resulting intellectual property on-chain, turning years of locked, illiquid scientific output into assets with price discovery and secondary markets.
Molecule's core innovation is attaching legal IP rights to an NFT, creating an asset class that a community can co-own and govern. The platform spans longevity, brain health, women's health, psychedelics, cell therapy and climate research, and is the tokenization engine behind the Bio Protocol BioDAO ecosystem.
How IP-NFTs and IP Tokens work
An IP-NFT is a single non-fungible token that carries the legal rights to a research project — its data, licensing terms and any downstream commercial upside. Molecule's open-source IP-NFT contracts reached V2 in 2024, standardizing this as reusable building blocks for the DeSci economy.
A single NFT is a poor governance and funding instrument, so Molecule added a Tokenizer contract that minted an ERC-20 IP Token (IPT) against an IP-NFT. Fractionalizing the IP-NFT into IPTs distributed ownership across many holders, funded the research through their purchases, and let that group of holders collectively govern the asset as it moved through the R&D pipeline. IPTs can also gate access to proprietary data and route IP-licensing revenue back to holders.
This is the on-chain analogue of a cap table for a research program — a design that sits squarely inside the DAO tokenomics question of how a token confers real economic and governance rights rather than pure speculation. In 2025 Molecule extended the model toward bridging tokenized IP into the wider real-world-asset (RWA) market.
V3: the Lab replaces the IP-NFT
That first-generation stack is now history. Molecule's contract index heads its Ethereum and Sepolia IPNFT sections “UNMAINTAINED” and lists the live deployment as “Molecule Labs core (v0.1.0)” on Base. The V3 primitive is a Lab: “an NFT (ERC-721) that is permanently bound to its own smart contract wallet (ERC-6551)” with account abstraction (ERC-4337), installable modules (ERC-7579) and an attestation registry (ERC-7484) gating what can be installed. The research project is no longer a token pointing at an asset; it is an account that holds its own treasury, data anchor and licences, and transferring the LabNFT hands over the whole thing in one ERC-721 transfer.
Tokenization moved with it: the OclTokenizer deploys one fractional ERC-20 IP Token per Lab, gated by a signed membership agreement, each as an EIP-1167 clone with its own address. Molecule also documents a Coin-to-Company module that states plainly that “Tokens are not equity” and routes holders who want shares through a lock-and-KYC path into ordinary off-chain share agreements. The full generational comparison is on the IP-NFTs and IP Tokens page.
How much of that V3 stack is in use is now measurable, and the two halves have diverged. Read off Base mainnet on 17 August 2026, the LabNFT has minted 74 Labs, all of them inside the 39 days between 8 July and 16 August 2026, across 47 distinct controllers. The OclTokenizer has issued none: its whole event log is seven administrative entries, and it has zero internal transactions, so it has never deployed the EIP-1167 clone that an IPT is. The ownership half of V3 is live and the fractionalization half has not been exercised once, which means every IP Token that actually funded research still sits on the unmaintained Ethereum contracts. Full figures and method on the IP-NFTs and IP Tokens page.
IP as a treasury asset
For a science DAO, the tokenized IP is not a side product — it is the treasury's core holding. A VitaDAO or AthenaDAO funds a study, receives an IP-NFT, and that asset (plus any licensing income) is what the community stewards. This makes treasury management for a DeSci DAO a question of managing a portfolio of illiquid, high-variance research bets rather than a stack of liquid tokens, and it is why the Molecule + Bio Protocol stack pairs IP tokenization with a launchpad and staking layer that keeps the community funding and curating the pipeline.
Products
Molecule Labs: the platform at labs.molecule.xyz, where researchers create and manage Labs — the on-chain research accounts that hold a project's token, treasury and data room.
Data rooms and access control: research files are client-side encrypted and released against on-chain conditions, with roles and expiry resolved by the AccessResolver — the mechanism that lets a Lab grant a collaborator or an AI agent scoped, expiring access without handing over ownership.
Documentation and contracts: developer and concept guides at docs.molecule.xyz, with the legacy IP-NFT contracts and subgraphs at github.com/moleculeprotocol/IPNFT.
Pump.science: Molecule founder/CEO Paul Kohlhaas also launched Pump.science, a Solana tokenized-experiment launchpad that funds longevity compound trials through freely tradeable tokens (Unchained) — the market-driven counterpart to Molecule's deliberative model.
How Caper approaches this
Molecule solves the asset side of DeSci — making research IP ownable and tradable. A caper addresses the organization side: it folds the fundraise (a bonding-curve sale), the treasury, on-chain proposals (PAYOUT / INVEST / DIVEST / VOTE) and an always-available, participation-weighted pro-rata exit into one primitive. A research community could hold its Molecule IP-NFT inside a caper's treasury and let members fund, direct and exit the project through a single contract rather than stitching together a token sale, a multisig and a separate governance tool.